Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Metabolic Changes with Thiazide or Beta Blocker Therapy for Essential Hypertension (Main Study)
2004-004329-90Phase 4Completed
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of atenolol, bendroflumethiazide, nebivolol, amiloride and hydrochlorothiazide in essential hypertension (7 arms), sponsored by Cambridge University Hospitals NHS Foundation Trust. Started Feb 2005; status: completed.
02
Drugs
atenololbendroflumethiazidenebivololamiloridehydrochlorothiazide
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2004-004329-90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004329-90.